Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was removed, along with a revision note.SummaryDifference0.6%

- Check19 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4, indicating a minor site version update.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a revision label updated from v3.5.3 to v3.5.4, indicating a small backend/software update rather than any change to the study details or visible content.SummaryDifference0.1%

- Check48 days agoChange DetectedIndiana University has been added to the collaborators/investigators section, replacing Indiana University School of Medicine. This reflects a shift in the listed institutional affiliation associated with the study team.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer revision/version number was updated from “v3.5.2” to “v3.5.3.” This reflects a site/package update rather than a change to the clinical trial’s content.SummaryDifference0.1%

- Check70 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.